This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel.
The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply.
Table of Contents
|1 Background and Study Task||7-15|
|2 Molybdenum-99/Technetium-99m Production and Use||16-30|
|3 Molybdenum-99/Technetium-99m Supply||31-54|
|4 Molybdenum-99/Technetium-99m Supply Reliability||55-65|
|5 Molybdenum-99/Technetium-99m Demand||66-79|
|6 Molybdenum-99/Technetium-99m Production Costs||80-89|
|7 Conversion to LEU-Based Production of Molybdenum-99: Technical Considerations||90-100|
|8 Conversion to LEU-Based Production of Molybdenum-99: Regulatory Considerations||101-107|
|9 Conversion to LEU-Based Production of Molybdenum-99: General Approaches and Timing||108-113|
|10 Conversion to LEU-Based Production of Molybdenum-99: Prospects and Feasibility||114-141|
|11 Progress in Eliminating HEU Use||142-162|
|Appendix A: Section 630 of the Energy Policy Act of 2005||169-172|
|Appendix B: Biographical Sketches of Committee Members||173-180|
|Appendix C: Presentations and Visits||181-183|
|Appendix D: Alternative Molybdenum-99 Production Processes||184-189|
|Appendix E: Correspondence with Atomic Energy of Canada Limited||190-193|
|Appendix F: Present Value Calculation||194-195|
|Appendix G: Glossary||196-199|
|Appendix H: Acronyms||200-202|
Find relevant information like your own rough draft from among the thousands of reports available for free at NAP.edu. Copy and paste up to 8 pages of content—whether from your own draft or an outside article—and Reference Finder will recommend NAP publications related to your text.
View Reference Finder
The National Academies Press (NAP) has partnered with Copyright Clearance Center's Rightslink service to offer you a variety of options for reusing NAP content. Through Rightslink, you may request permission to reprint NAP content in another publication, course pack, secure website, or other media. Rightslink allows you to instantly obtain permission, pay related fees, and print a license directly from the NAP website. The complete terms and conditions of your reuse license can be found in the license agreement that will be made available to you during the online order process. To request permission through Rightslink you are required to create an account by filling out a simple online form. The following list describes license reuses offered by the National Academies Press (NAP) through Rightslink:
Click here to obtain permission for the above reuses. If you have questions or comments concerning the Rightslink service, please contact:
Rightslink Customer Care
Tel (toll free): 877/622-5543
To request permission to distribute a PDF, please contact our Customer Service Department at 800-624-6242 for pricing.
To request permission to translate a book published by the National Academies Press or its imprint, the Joseph Henry Press, please click here to view more information.
Loading stats for Medical Isotope Production Without Highly Enriched Uranium...